The Pharmaceutical Industry and Health Professional Services Name Institution The Pharmaceutical Industry and Health Professional Services The U.S. drug supply chain is one of the safest in the world and is firmly controlled by the Food and Drug Administration, which ensures that all drugs available in the market are approved and safe for use on patients and are effective for the indications they a designed for (FDA, 2014). However, the supply chain is becoming increasingly complex as the supply chain is becoming more global and there are many players within and outside the US, which brings challenges in ensuring that the drugs in the market are fit for use. The main threats from the complexities of the drugs chain supply is from threats, which include counterfeiting, cargo theft, substandard drugs imports, and drug diversion, which could result to unsafe and ineffective drugs in the US supply chain. It is the duty of the FDA to safeguard the integrity of the US drug supply chain through activities and initiatives that protect consumers from exposure to unapproved and potentially ineffective drugs (FDA, 2014). In order to ensure that drugs supplied by Get Well Drugs meet the standards set by FDA, it is